PDCD1 and myeloid sarcoma: In patients carrying the PD-1 polymorphism, mutations in the regulatory region of the PD-1 gene may affect PD-1 signal transduction, thereby impairing the function of inhibiting T cell proliferation mediated by PD-1 and accelerating disease progression in MS patients [58].